Marylyn Rigby
Investor Relations Contact at Revolo Biotherapeutics Ltd.
Network origin in Marylyn Rigby first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom.
11
| Holding Company | Pharmaceuticals: Major | 11 |
SteadyMed Therapeutics, Inc.
 SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA.
8
| Holding Company | Medical/Nursing Services | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marylyn Rigby via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BIOPLUS ACQUISITION CORP. | Financial Conglomerates | Chairman Director/Board Member | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Flow Pharma, Inc.
 Flow Pharma, Inc. Internet Software/ServicesTechnology Services Flow Pharma, Inc.operates as t-cell based vaccine delivery platform. The company was founded by Reid Rubsamen and is headquartered in Pleasant Hill, CA. | Internet Software/Services | Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
ProterixBio, Inc.
 ProterixBio, Inc. Medical SpecialtiesHealth Technology ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA. | Medical Specialties | Director/Board Member | |
Stark & Roth LLC
 Stark & Roth LLC Investment ManagersFinance Founded in 1992 by Brian Stark and Michael Roth, Stark & Roth LLC is a registered investment advisor and hedge fund manager located in Milwaukee, Wisconsin. The firm is a subsidiary of Stark & Roth Holding, Inc.. Stark & Roth also does business as Stark Investments. | Investment Managers | Chief Executive Officer | |
Advanced Cell Diagnostics, Inc.
 Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Synchroneuron, Inc.
 Synchroneuron, Inc. Pharmaceuticals: MajorHealth Technology Synchroneuron, Inc. develops therapies for tardive dyskinesia (TD) and other neuropsychiatric disorders. It offers a novel treatment for movement disorders, utilizing a drug with simultaneous effects on excitatory and inhibitory neurotransmission. The company was founded by Kei-Lai L. Fong, William D. Kerns, Marc R. Cote and Barry S. Fogel in 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Major | Director/Board Member | |
Serica Technologies, Inc.
 Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Serica Technologies, Inc. produces silk-based biomaterial products for tissue rejuvenation. The company develops knee ligament replacements from silk biomaterial. The company was founded on May 31, 2000 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Atreaon, Inc.
 Atreaon, Inc. Pharmaceuticals: OtherHealth Technology Atreaon, Inc. develops proteins for diseases treatment. It operates as a pharmaceutical company that develops medicines for the treatment of arthritis. The company was founded on December 19, 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Other | Director/Board Member | |
| Tufts University School of Medicine | College/University | Doctorate Degree | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Corporate Officer/Principal | |
| AMYLYX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NUCANA PLC | Biotechnology | Director/Board Member | |
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Director/Board Member | |
Artugen Therapeutics Ltd.
 Artugen Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Artugen Therapeutics Ltd. develops precision treatments for infections. The company was founded in 2015 and is headquartered in Concord, MA. | Pharmaceuticals: Generic | Director/Board Member | |
K-Gen, Inc.
 K-Gen, Inc. Miscellaneous Commercial ServicesCommercial Services K-Gen, Inc. is an American biotechnology company. The private company is based in San Francisco. | Miscellaneous Commercial Services | Director/Board Member | |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Equipment/Instruments | Director/Board Member | |
Kedalion Therapeutics, Inc.
 Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Afecta Pharmaceuticals, Inc.
 Afecta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afecta Pharmaceuticals, Inc. is a private company based in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree | |
| Clemson University | College/University | Undergraduate Degree | |
| ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Executive Officer | |
OS Therapies, Inc.
 OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director/Board Member | |
Petrichor Healthcare Capital Management LP
 Petrichor Healthcare Capital Management LP Investment ManagersFinance Petrichor Healthcare Capital Management LP (Petrichor) is a private equity firm founded in 2016 by Tadd Wessel. The firm headquartered in New York. | Investment Managers | Consultant / Advisor | |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Biotechnology | Director/Board Member | |
| SUPERNUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
| Medical University of South Carolina | College/University | Doctorate Degree | |
| Licensing Executives Society | Corporate Officer/Principal | ||
Lupin Pharmaceuticals, Inc.
 Lupin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lupin Pharmaceuticals, Inc. provides pharmaceutical products healthcare professionals and patients across geographies. The firm offers generic, specialty and active pharmaceutical ingredient drugs for diabetic, anti-inflammatory and respiratory therapy. The company was founded in 2003 and is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ATEA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Corporate Officer/Principal | |
| Arthur M Spiro Institute For Entrepreneurial Leadrship | College/University | Chairman | |
| ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 46 |
| United Kingdom | 3 |
| Israel | 2 |
| Ireland | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 5 |
| Technology Services | 3 |
Operational
| Director/Board Member | 103 |
| Corporate Officer/Principal | 38 |
| Independent Dir/Board Member | 25 |
| Chief Tech/Sci/R&D Officer | 23 |
| Chief Executive Officer | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Peter Greenleaf | 31 |
| Isaac Cheng | 25 |
| Marla Persky | 19 |
| Stephen Farr | 18 |
| Donald Huffman | 16 |
| Jonathan Rigby | 16 |
| Elizabeth Cermak | 13 |
| Babatunde Otulana | 13 |
| Jones Woody Bryan | 12 |
| Pericles Calias | 11 |
| Brian Stark | 11 |
| Jeff Myers | 9 |
| Glen Giovannetti | 9 |
| Peter D. Noymer | 8 |
| Niles A. Fleischer | 5 |
- Stock Market
- Insiders
- Marylyn Rigby
- Company connections
